Marked asymmetry of putaminal pathology in an MSA-P patient with Pisa syndrome

Movement Disorders

Volumn 19, Issue 4, 2004, Pages 470-472

  Hozumi, Isao ^a   Piao, Y S ^b   Inuzuka, T ^a   Matsuyama, Z ^a   Yamada, Y ^a   Hara, A ^a   Hirose, T ^a   Tsuchiya, K ^a   Takahashi, H ^b  

^a GIFU UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Axial dystonia; Multiple system atrophy; Striatonigral degeneration

Indexed keywords

DIAZEPAM; LEVODOPA; TRIHEXYPHENIDYL;

ADULT; ANAMNESIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; CAUSE OF DEATH; DISEASE ASSOCIATION; DYSTONIA; ELECTROMYOGRAPHY; EXTRAPYRAMIDAL SYNDROME; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PATHOPHYSIOLOGY; PISA SYNDROME; PRIORITY JOURNAL; PUTAMEN; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ATROPHY; DYSTONIA; FATAL OUTCOME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSONIAN DISORDERS; PUTAMEN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 2342442658     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10668     Document Type: Article

References (11)

1. Rivest J, Quinn N, Marsden CD. Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurology 1990;40:1571-1578.
2. Wenning GK, Tison F, Shlomo B, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997; 12:133-147.
3. Boesch SM, Wenning GK, Ransmayr G, Poewe W. Dystonia in multiple system atrophy. J Neurol Neurosurg Psychiatry 2002;72:300-303.
4. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-243.
5. Ekbom K, Lindholm H, Ljungberg L. New dystonic syndrome associated with butyrophenone therapy. J Neurol 1972;202:94-103.
6. Stübner S, Padberg F, Grohmann R, et al. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry 2000;61:569-574.
7. Patel S, Tariot PN, Hamill RW. Pisa syndrome without neuroleptic exposure in a patient with dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 1991;4:48-51.
8. Colosimo C. Pisa syndrome in a patient with multiple system atrophy. Mov Disord 1998;13:607-609.
9. Wenning GK, Seppi K, Tison F, Jellinger K. A novel grading scale for striatonigral degeneration (multiple system atrophy). J Neural Transm 2002;109:307-320.
10. Miyaoka T, Seno H, Yamamori C, Inagaki T, Itoga M, Tsubouchi K, Horiguchi J. Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report. J Clin Psychiatry 2001;62: 573-574.
11. Suzuki T, Hori T, Baba A, Abe S, Shiraishi H, Moroji T, Piletz JE. Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa syndrome). J Clin Psychopharmacol 1999;19:277-280.